Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Obesity
|
1111 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.800 | 0.843 | 51 | 1995 | 2019 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.100 | 0.882 | 34 | 1995 | 2017 | ||||
Metabolic Syndrome X
|
591 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.100 | 1.000 | 16 | 1996 | 2019 | ||||
Hypertensive disease
|
1085 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.080 | 1.000 | 8 | 1999 | 2017 | ||||
Insulin resistance syndrome
|
15 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.070 | 1.000 | 7 | 1996 | 2003 | ||||
Diabetes Mellitus
|
824 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.050 | 1.000 | 5 | 1996 | 2018 | ||||
Overactive Bladder
|
3 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.050 | 1.000 | 5 | 2007 | 2015 | ||||
Hyperuricemia
|
76 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.040 | 1.000 | 4 | 2007 | 2013 | ||||
Coronary heart disease
|
1178 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.030 | 0.667 | 3 | 2005 | 2014 | ||||
Diabetes
|
710 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.030 | 1.000 | 3 | 1996 | 2014 | ||||
Essential Hypertension
|
293 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.030 | 1.000 | 3 | 1999 | 2018 | ||||
Gestational Diabetes
|
224 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.030 | 0.333 | 3 | 2004 | 2007 | ||||
Cardiovascular Diseases
|
711 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.020 | 1.000 | 2 | 2012 | 2014 | ||||
Coronary Arteriosclerosis
|
440 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.020 | 1.000 | 2 | 2005 | 2014 | ||||
Coronary Artery Disease
|
1577 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.020 | 0.500 | 2 | 2005 | 2014 | ||||
Dyslipidemias
|
184 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.020 | 1.000 | 2 | 1997 | 2006 | ||||
Hyperlipidemia
|
83 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.020 | 0.500 | 2 | 2001 | 2003 | ||||
Metabolic Diseases
|
50 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.020 | 1.000 | 2 | 2001 | 2016 | ||||
Obesity, Morbid
|
49 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.020 | 1.000 | 2 | 1997 | 2007 | ||||
Pediatric Obesity
|
67 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.020 | 1.000 | 2 | 2000 | 2015 | ||||
Polycystic Ovary Syndrome
|
363 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.020 | 0.500 | 2 | 2000 | 2005 | ||||
Adolescent Obesity
|
9 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||
Arteriosclerosis
|
267 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Atherosclerosis
|
281 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Breast Carcinoma
|
2793 | 0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 | 0.010 | 1.000 | 1 | 2007 | 2007 |